Task Force Grants Broad Support For Colorectal Cancer Screening Tools
This article was originally published in The Gray Sheet
Executive Summary
The US Preventive Services Task Force said colorectal cancer screening is effective for those aged 50 to 75. It recognizes the potential for a range of methods, from standard colonoscopy to CT colonography, to blood and fecal DNA testing, to be used to increase screening rates. The recommendations could help drive coverage and adoption for several firms' products.
You may also be interested in...
Medicare Denies Coverage Of CT Colonography For Cancer Screening
The hopes of imaging equipment and software makers, the American Cancer Society and radiologists were dashed with CMS' final decision not to cover computed tomography colonography for colorectal cancer screening
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.